Tulio E. Rodriguez

1.4k total citations
53 papers, 724 citations indexed

About

Tulio E. Rodriguez is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Tulio E. Rodriguez has authored 53 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 19 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Tulio E. Rodriguez's work include Hematopoietic Stem Cell Transplantation (14 papers), Multiple Myeloma Research and Treatments (11 papers) and Acute Myeloid Leukemia Research (7 papers). Tulio E. Rodriguez is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Multiple Myeloma Research and Treatments (11 papers) and Acute Myeloid Leukemia Research (7 papers). Tulio E. Rodriguez collaborates with scholars based in United States, Chile and Canada. Tulio E. Rodriguez's co-authors include Patrick J. Stiff, Amir A. Toor, Scott E. Smith, Mala Parthasarathy, Augustin Ferrant, Jeffrey H. Lipton, Michael Schmitt, Hermann Einsele, Roy F. Chemaly and Lynne Strasfeld and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tulio E. Rodriguez

50 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tulio E. Rodriguez United States 14 296 223 214 147 92 53 724
H. Einsele Germany 13 343 1.2× 344 1.5× 321 1.5× 155 1.1× 120 1.3× 22 782
Manuel Abecasis Portugal 11 230 0.8× 220 1.0× 488 2.3× 180 1.2× 198 2.2× 24 865
Naoki Hatakeyama Japan 14 116 0.4× 142 0.6× 184 0.9× 116 0.8× 138 1.5× 50 572
Javier López‐Jiménez Spain 15 121 0.4× 231 1.0× 234 1.1× 213 1.4× 113 1.2× 60 729
Marcie Tomblyn United States 10 164 0.6× 194 0.9× 318 1.5× 78 0.5× 79 0.9× 21 551
Mathew Simcock Switzerland 18 188 0.6× 272 1.2× 164 0.8× 178 1.2× 61 0.7× 46 926
Jared Klein United States 14 290 1.0× 229 1.0× 263 1.2× 66 0.4× 165 1.8× 32 810
Gülyüz Öztürk Türkiye 16 128 0.4× 94 0.4× 211 1.0× 87 0.6× 142 1.5× 60 596
Stuart Seropian United States 13 107 0.4× 297 1.3× 342 1.6× 255 1.7× 190 2.1× 26 761
Janet Poole South Africa 14 83 0.3× 153 0.7× 251 1.2× 120 0.8× 133 1.4× 29 612

Countries citing papers authored by Tulio E. Rodriguez

Since Specialization
Citations

This map shows the geographic impact of Tulio E. Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tulio E. Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tulio E. Rodriguez more than expected).

Fields of papers citing papers by Tulio E. Rodriguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tulio E. Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tulio E. Rodriguez. The network helps show where Tulio E. Rodriguez may publish in the future.

Co-authorship network of co-authors of Tulio E. Rodriguez

This figure shows the co-authorship network connecting the top 25 collaborators of Tulio E. Rodriguez. A scholar is included among the top collaborators of Tulio E. Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tulio E. Rodriguez. Tulio E. Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rodriguez, Tulio E., et al.. (2021). Persistent SARS-CoV-2 infectivity greater than 50 days in a case series of allogeneic peripheral blood stem cell transplant recipients. SHILAP Revista de lepidopterología. 3. 100057–100057. 8 indexed citations
3.
Rodby, Roger A., David Cimbaluk, Parameswaran Venugopal, et al.. (2019). When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds. Clinical Lymphoma Myeloma & Leukemia. 19(6). e251–e258. 7 indexed citations
4.
Mumby, Patricia, Todd Doyle, William Adams, et al.. (2017). Utility of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in hematopoietic stem cell transplantation (HSCT).. Journal of Clinical Oncology. 35(15_suppl). 10046–10046. 3 indexed citations
5.
Rodriguez, Tulio E., et al.. (2016). Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. Biology of Blood and Marrow Transplantation. 22(8). 1391–1396. 25 indexed citations
6.
Yazigi, R, et al.. (2015). Ovarian granulosa cell tumour and letrozole: A case report. Journal of Obstetrics and Gynaecology. 36(1). 122–123. 2 indexed citations
7.
Freytes, César O., Juan J. Toro, Rosa F. Yeh, et al.. (2014). Safety and Efficacy of Targeted-Dose Busulfan and Bortezomib as a Conditioning Regimen for Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Blood Progenitor Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(12). 1949–1957. 4 indexed citations
8.
9.
Rodriguez, Tulio E.. (2013). Neurologic complications of bone marrow transplantation. Handbook of clinical neurology. 121. 1295–1304. 13 indexed citations
10.
Choi, Sung Won, Patrick J. Stiff, Kenneth R. Cooke, et al.. (2012). TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes. Biology of Blood and Marrow Transplantation. 18(10). 1525–1532. 45 indexed citations
11.
Wang, Michael, Charlesnika T. Evans, Tulio E. Rodriguez, Dale N. Gerding, & Stuart Johnson. (2012). Clostridium difficileInfection and Limitations of Markers for Severity in Patients with Hematologic Malignancy. Infection Control and Hospital Epidemiology. 34(2). 127–132. 33 indexed citations
12.
Ricci, Paolo, et al.. (2011). A Rare Case of Nine Twisted Adnexal Torsion Successfully Resolved by Conservative Laparoscopic Detorsion. Journal of Minimally Invasive Gynecology. 18(5). 551–552. 1 indexed citations
13.
Marty, Francisco M., Per Ljungman, Genovefa A. Papanicolaou, et al.. (2011). Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. The Lancet Infectious Diseases. 11(4). 284–292. 252 indexed citations
14.
Toor, Amir A., Tulio E. Rodriguez, Herbert L. Mathews, et al.. (2008). Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT. Bone Marrow Transplantation. 42(11). 723–731. 10 indexed citations
15.
Mullane, Kathleen M., et al.. (2007). Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections. Transplant Infectious Disease. 9(2). 89–96. 25 indexed citations
16.
Fung, Henry C., Patrick J. Stiff, Jeff Schriber, et al.. (2007). Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 13(5). 594–600. 37 indexed citations
17.
Smith, Scott E., Amir A. Toor, Tulio E. Rodriguez, & Patrick J. Stiff. (2006). The administration of polymerized human hemoglobin (pyridoxylated) to a jehovah's witness after submyeloablative stem cell transplantation complicated by delayed graft failure. Comprehensive Therapy. 32(3). 172–175. 8 indexed citations
18.
Stiff, Patrick J., Patricia Mumby, Tulio E. Rodriguez, et al.. (2006). Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis. Bone Marrow Transplantation. 38(11). 757–764. 16 indexed citations
19.
Stiff, Patrick J., Patricia Mumby, Nancy Porter, et al.. (2006). Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation. Bone Marrow Transplantation. 37(5). 479–484. 16 indexed citations
20.
García-Sánchez, José, et al.. (1984). Burkitt’s Lymphoma in Cuba. Oncology. 41(1). 13–18. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Einsele Breakdown of academic impact, for papers by Manuel Abecasis Breakdown of academic impact, for papers by Naoki Hatakeyama Breakdown of academic impact, for papers by Javier López‐Jiménez Breakdown of academic impact, for papers by Marcie Tomblyn Breakdown of academic impact, for papers by Mathew Simcock Breakdown of academic impact, for papers by Jared Klein Breakdown of academic impact, for papers by Gülyüz Öztürk Breakdown of academic impact, for papers by Stuart Seropian Breakdown of academic impact, for papers by Janet Poole
Rankless by CCL
2026